Treatment of Hepatitis C
Top Cited Papers
- 13 August 2014
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (6), 631-640
- https://doi.org/10.1001/jama.2014.7085
Abstract
Kohli and coauthors review the safety, efficacy, and tolerability of current approved interferon-based regimens and oral interferon-free regimens for treating hKeywords
This publication has 52 references indexed in Scilit:
- Genetic Diversity of Recently Acquired and Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections in US Blood DonorsThe Journal of Infectious Diseases, 2012
- Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis CJournal of Viral Hepatitis, 2011
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatology, 2011
- Hepatitis C Virus Genotypes in Clinical Specimens Tested at a National Reference Testing Laboratory in the United StatesJournal of Clinical Microbiology, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patientsJournal of Hepatology, 2011
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysisJournal of Hepatology, 2009
- Complex dynamics of hepatitis B virus resistance to adefovirHepatology, 2008